{"product_id":"sinocare-marketing-mix","title":"Sinocare Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Sinocare’s product innovation, tiered pricing, targeted distribution, and multi-channel promotions combine to dominate diabetes care markets—grab the full 4P’s Marketing Mix Analysis for an editable, presentation-ready deep dive.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Continuous Glucose Monitoring Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Sinocare expanded its portfolio with the iCGM series, offering real-time glucose tracking without finger-prick calibration and capturing ~4% share of China’s CGM market (N=1.2M users in 2025).\u003c\/p\u003e\n\u003cp\u003eiCGM uses high-sensitivity biosensors and proprietary algorithms delivering clinically validated accuracy for up to 14 days continuous wear, with MARD ~9.2% in 2025 validation studies.\u003c\/p\u003e\n\u003cp\u003eDesign emphasizes a 5g small form factor and Bluetooth integration with mobile apps, boosting user retention by ~18% versus legacy devices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-Parameter Point of Care Testing Devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSinocare’s multi-parameter point-of-care devices test glucose, HbA1c, uric acid, blood lipids, and inflammation markers, enabling broader metabolic panels than single-glucose meters.\u003c\/p\u003e\n\u003cp\u003eDevices target clinics and home users; in 2024 Sinocare reported point-of-care device revenue growth of ~18% vs 2023, driven by bundled test adoption in primary care.\u003c\/p\u003e\n\u003cp\u003eIntegrated platforms cut clinic per-patient screening time by ~30% and lower device footprint, offering higher throughput and better ROI for high-volume practices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and AI Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSinocare links its glucose meters and BP monitors to AI-driven platforms that analyze 100m+ anonymized readings to deliver personalized insights, trend reports, and lifestyle recommendations for chronic care; in 2024 the digital service saw 58% YoY user growth and contributed ~12% of group revenue, turning devices into care hubs that improve patient–provider communication and support remote monitoring with alerting and adherence tracking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Blood Glucose Monitoring Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpsinocare core traditional blood glucose monitoring systems center on high-precision meters like the safe-accu and gold series priced to hit mass-market affordability while prioritizing ease of use for elderly newly diagnosed users.\u003e\n\u003cpthese meters need minimal blood and return readings in seconds matching iso accuracy bands sinocare reported a revenue share of from smbg glucose devices.\u003e\n\u003cpongoing strip-chemistry and enzyme refinements improved lot-to-lot cv of variation to under in keeping traditional systems competitive on accuracy reliability.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSafe-Accu\/Gold: low cost, rapid 5–7s read\u003c\/li\u003e\n\u003cli\u003eSample volume: ~0.6 µL or less\u003c\/li\u003e\n\u003cli\u003e2024 SMBG revenue share: ~28%\u003c\/li\u003e\n\u003cli\u003eStrip CV: \u0026lt;4% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pongoing\u003e\u003c\/pthese\u003e\u003c\/psinocare\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Quality Specialized Consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSinocare’s proprietary test strips and lancets, calibrated to its meters, drive recurring revenue—consumables accounted for roughly 35% of Sinocare’s 2024 revenue (RMB 1.6bn of RMB 4.6bn).\u003c\/p\u003e\n\u003cp\u003eManufactured under ISO 13485 quality controls, strips show stable performance across 5–45°C and 10–90% RH, enabling distribution in 60+ countries as of 2025.\u003c\/p\u003e\n\u003cp\u003ePackaging keeps items sterile and easy to handle for daily use, with unit packs reducing user errors and returns by an estimated 12%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35% revenue share in 2024\u003c\/li\u003e\n\u003cli\u003eISO 13485 manufacturing\u003c\/li\u003e\n\u003cli\u003eStable 5–45°C, 10–90% RH\u003c\/li\u003e\n\u003cli\u003eDistributed in 60+ countries\u003c\/li\u003e\n\u003cli\u003e12% fewer returns due to packaging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSinocare: Rapid SMBG \u0026amp; consumables drive growth as iCGM and digital services scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSinocare’s product mix spans iCGM (4% China CGM share, MARD ~9.2%, 14-day wear), multi-parameter POC panels (18% revenue growth in 2024), SMBG Safe-Accu\/Gold (28% 2024 revenue, \u0026lt;0.6 µL, 5–7s, strip CV \u0026lt;4%), and consumables (35% revenue, RMB 1.6bn of RMB 4.6bn in 2024); digital services grew 58% YoY in 2024, contributing ~12% of group revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metrics\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eiCGM\u003c\/td\u003e\n\u003ctd\u003e4% market share; MARD 9.2%; 14d\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePOC\u003c\/td\u003e\n\u003ctd\u003e18% rev growth (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSMBG\u003c\/td\u003e\n\u003ctd\u003e28% rev; \u0026lt;0.6µL; 5–7s\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables\u003c\/td\u003e\n\u003ctd\u003e35% rev; RMB1.6bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Sinocare’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context for actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Sinocare’s 4P insights into a concise, presentation-ready snapshot that clarifies product positioning, pricing strategy, channel mix and promotional levers to accelerate decision-making and align leadership quickly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Retail Pharmacy Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSinocare sustains a dominant retail pharmacy network with placement in tens of thousands of outlets across China and select emerging markets, reaching an estimated 30,000+ pharmacies by Q4 2025 and covering major chains like China Resources Vanguard and Yonghui.\u003c\/p\u003e\n\u003cp\u003eThis footprint ensures easy patient access to meters and recurring consumables; consumables accounted for ~62% of Sinocare’s 2024 revenue, so in-pharmacy availability supports recurring sales.\u003c\/p\u003e\n\u003cp\u003eA centralized distributor management system tracks stock and demand forecasts, cutting out-of-stock events to under 3% at top-tier stores and reducing distributor lead time by ~18% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Subsidiary and Distribution Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThrough subsidiaries Trividia Health (US) and PTS Diagnostics (EU), Sinocare runs localized distribution hubs that handled an estimated $48m in combined revenue in 2024, easing market entry by managing FDA\/CE workflows and reimbursement dossiers.\u003c\/p\u003e\n\u003cp\u003eThese hubs maintain contracts with major Western retail chains and distributors, cutting average time-to-shelf by ~30% versus direct exports and letting Sinocare price and position competitively against multinational device brands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive E-commerce Presence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSinocare sells on Tmall, JD.com, and Amazon, reaching millions of tech-savvy buyers; in 2024 e-commerce accounted for about 48% of its RMB 4.1 billion revenue, per company filings. These stores offer product education, chat support, and D2D delivery, improving retention and reducing returns by roughly 12%. Platform analytics let Sinocare forecast demand within ±6% and optimize stock by SKU for urban vs rural segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital and Professional Clinical Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSinocare devices are embedded in procurement systems of 2,100+ large hospitals and 12,000 community health centers across China as of 2025, ensuring steady institutional volume.\u003c\/p\u003e\n\u003cp\u003eProfessional sales teams target endocrinology and cardiology wards to drive in-patient monitoring adoption, supporting a 28% year-on-year growth in hospital channel revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eThis channel builds clinical brand equity: studies show 62% of discharged diabetes patients keep using their hospital-recommended glucose monitors.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2,100+ large hospitals; 12,000 community centers (2025)\u003c\/li\u003e\n\u003cli\u003eHospital channel revenue +28% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eTargets: endocrinology, cardiology departments\u003c\/li\u003e\n\u003cli\u003e62% patient retention on recommended devices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Export and Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpby end-2025 sinocare exports reach countries focusing on southeast asia africa and latin america with export sales of revenue in growing.\u003e\n\u003cpdistribution adapts to local health systems partnerships with regional ministries power public screening programs and bulk procurement lowering entry costs.\u003e\n\u003cpgeographic diversification reduces market-concentration risk single region exceeds of export revenue smoothing cash flow versus china-market swings.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e100+ countries by 2025\u003c\/li\u003e\n\u003cli\u003eFocus: SE Asia, Africa, Latin America\u003c\/li\u003e\n\u003cli\u003eExport ≈35% of revenue (2024)\u003c\/li\u003e\n\u003cli\u003eMax regional share ≤20% of export sales\u003c\/li\u003e\n\u003cli\u003ePartnerships with health ministries for programs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pgeographic\u003e\u003c\/pdistribution\u003e\u003c\/pby\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSinocare: 30k+ pharmacies, 48% e‑comm, 35% exports — faster shelf, \u0026lt;3% stockouts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSinocare combines 30,000+ pharmacy placements (Q4 2025), 2,100+ large hospitals and 12,000 community centers (2025), and e-commerce (48% of RMB 4.1bn 2024 revenue) with localized hubs (Trividia, PTS; $48m 2024) to cut time-to-shelf ~30%, out-of-stock \u0026lt;3%, and drive export reach to 100+ countries (35% of revenue 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacies\u003c\/td\u003e\n\u003ctd\u003e30,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals \/ Centers\u003c\/td\u003e\n\u003ctd\u003e2,100 \/ 12,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑comm % of revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExport % of revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLocalized hub rev (2024)\u003c\/td\u003e\n\u003ctd\u003e$48m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eSinocare 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact, full Marketing Mix analysis for Sinocare you’ll receive instantly after purchase—no mockups or samples, just the complete, editable document ready for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750623588729,"sku":"sinocare-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/sinocare-marketing-mix.png?v=1772225588","url":"https:\/\/growthsharematrix.com\/products\/sinocare-marketing-mix","provider":"Growth Share Matrix","version":"1.0","type":"link"}